Bucillamine

MUSCULO-SKELETAL SYSTEM

Key facts

Bucillamine is a drug catalogued in DrugCentral.

• ATC code: M01CC02 (Penicillamine and similar agents).
• Molecular formula: C7H13NO3S2; molecular weight 223.31 g/mol.

ATC classification

ATC code	Therapeutic hierarchy
M01CC02	MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › SPECIFIC ANTIRHEUMATIC AGENTS › Penicillamine and similar agents

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Lymphoproliferative disorder	240.4
Interstitial lung disease	102.7
Diffuse large B-cell lymphoma	84.8
Epstein-Barr virus associated lymphoproliferative disorder	76.7
Epstein-Barr virus infection	55.2
Pneumocystis jirovecii pneumonia	42.3

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Bucillamine is on its molecule page.

• Molecular formula: C₇H₁₃NO₃S₂
• Molecular weight: 223.31 g/mol
• CAS number: 65002-17-7
• InChIKey: VUAFHZCUKUDDBC-BYPYZUCNSA-N
• PubChem CID: 656604

CC(C)(S)C(=O)N[C@@H](CS)C(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Bucillamine?

Bucillamine has the molecular formula C7H13NO3S2 and a molecular weight of 223.31 g/mol.

Sources

• DrugCentral drug card 414 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL80830 — compound record and bioactivity
• PubChem CID 656604 — chemical identifiers
• DrugBank DB12160 — drug record
• FDA UNII R80LRA5WTF — substance identity
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.